<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37015764</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Reversible blindness with macrophage activation syndrome: an unusual presentation of secondary antiphospholipid syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e253317</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2022-253317</ELocationID><Abstract><AbstractText>Blindness due to retinal vascular thrombosis is a dreadful complication of antiphospholipid syndrome (APS). The latter may be present in isolation (ie, primary) or may occur secondary to other connective tissue diseases like lupus. Here we present an adolescent girl with bilateral painless loss of vision as a result of central retinal vessel thrombosis due to secondary APS. Her condition was further complicated by the presence of autoimmune haemolytic anaemia and the development of macrophage activation syndrome while being evaluated for her blindness. Prompt treatment with glucocorticoids and anticoagulants could halt the devastating disease process.</AbstractText><CopyrightInformation>&#xa9; BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Debroop</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8965-0039</Identifier><AffiliationInfo><Affiliation>General Medicine, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India debroop_sengupta@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poddar</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Medicine, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bag</LastName><ForeName>Upamanyu</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>General Medicine, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Sandip</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Medicine, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055501" MajorTopicYN="Y">Macrophage Activation Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005128" MajorTopicYN="Y">Eye Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001766" MajorTopicYN="N">Blindness</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Haematology (incl blood transfusion)</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Retina</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37015764</ArticleId><ArticleId IdType="pmc">PMC10083791</ArticleId><ArticleId IdType="doi">10.1136/bcr-2022-253317</ArticleId><ArticleId IdType="pii">16/4/e253317</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Utz VM, Tang J. Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol 2011;95:454&#x2013;9. 10.1136/bjo.2010.182857</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2010.182857</ArticleId><ArticleId IdType="pubmed">20693557</ArticleId></ArticleIdList></Reference><Reference><Citation>Uludag G, Onghanseng N, Tran ANT, et al. . Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalmic Inflamm Infect 2021;11:11. 10.1186/s12348-021-00240-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12348-021-00240-8</ArticleId><ArticleId IdType="pmc">PMC8032459</ArticleId><ArticleId IdType="pubmed">33834305</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome. Autoimmun Rev 2007;6:409&#x2013;14. 10.1016/j.autrev.2006.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2006.11.005</ArticleId><ArticleId IdType="pubmed">17537387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hysa E, Cutolo CA, Gotelli E, et al. . Ocular microvascular damage in autoimmune rheumatic diseases: the pathophysiological role of the immune system. Autoimmun Rev 2021;20:102796. 10.1016/j.autrev.2021.102796</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102796</ArticleId><ArticleId IdType="pubmed">33722750</ArticleId></ArticleIdList></Reference><Reference><Citation>Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) 2007;46:1641&#x2013;7. 10.1093/rheumatology/kem158</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem158</ArticleId><ArticleId IdType="pubmed">17636180</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter J-I, Horne A, Aric&#xf3; M, et al. . HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124&#x2013;31. 10.1002/pbc.21039</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.21039</ArticleId><ArticleId IdType="pubmed">16937360</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G, Didona D, Stifano G, et al. . Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature. Case Rep Med 2015;2015:294041. 10.1155/2015/294041</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/294041</ArticleId><ArticleId IdType="pmc">PMC4439481</ArticleId><ArticleId IdType="pubmed">26064125</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker P, Moulinet T, Pontille F, et al. . An updated review of anti-ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev 2022;21:103013. 10.1016/j.autrev.2021.103013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.103013</ArticleId><ArticleId IdType="pubmed">34896652</ArticleId></ArticleIdList></Reference><Reference><Citation>Au A, O&#x2019;Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol 2004;32:87&#x2013;100. 10.1046/j.1442-9071.2004.00766.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-9071.2004.00766.x</ArticleId><ArticleId IdType="pubmed">14746601</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>